Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Kovogen LLC
Profile last edited on: 1/13/14      CAGE: 47GE9      UEI:

Business Identifier: studying a brain protein called RGS9-2
Year Founded
2006
First Award
2006
Latest Award
2010
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

168 Long Wharf Drive
Mystic, CT 06355
   (860) 501-1729
   abekovoor@yahoo.com
   N/A
Location: Single
Congr. District: 02
County: New London

Public Profile

Kovogen LLC is a life sciences start-up company, with ties to the University of Rhode Island, that is developing methods for predicting which individuals are more likely to get irreversible and debilitating side effects so that drug treatment can be optimized and tailored for individual patients.

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
2
Conversion Rate
100.00%
Phase I Dollars
$472,254
Phase II Dollars
$752,596
Total Awarded
$1,224,850

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2010 2 NIH $717,702
Project Title: Hyperpolarized 129-Xenon-Based Mri Probes For Brain Injury
2009 1 NIH $342,107
Project Title: Hyperpolarized 129-Xenon-based MRI Probes for Brain Injury
2007 2 NIH $507,148
Project Title: A Genetic Test for Drug-Induced Dyskinesia Risk

Key People / Management

  Abraham Kovoor -- President

  Jeremy Celver -- Scientific Director

Company News

Jan 05 2012
New Gene That Regulates Body Weight Discovered